Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Hypertrophic Cardiomyopathy & Implantable Cardioverter Defibrillator Assessment: (Subcutaneous vs Transvenous)

NCT05938283 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT05938283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05938283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Hypertrophic Cardiomyopathy & Implantable Cardioverter Defibrillator Assessment: (Subcutaneous vs Transvenous)
Lead sponsor
Barts & The London NHS Trust
Phase
Not applicable
Overall status
Completed
Start date
January 10, 2024
Completion date
January 7, 2026
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy, implantable cardioverter ventricular lead dysfunction or complication, implantable defibrillator user, ventricular arrythmia